Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment
More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment
Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
The use of steroids for the treatment of immune-related adverse events may have survival consequences.
Key changes include new N category descriptors, more stage III subgroups, new M1D designation.
The findings showed that only 29.1% of the skin cancers started in moles patients already had.
Risk factors include older age, white race, and receiving a kidney from a living donor.
While users had an overall 11% increased risk of melanoma, there wasn’t evidence that the drugs cause melanoma.
Researchers say skin cancer in these patients is likely due to more sun exposure.
Estimated 33% of overall risk is genetic; certain types of cancer have additional risk.